IL-1β is commonly secreted by various tumor cells and triggers a pro-inflammatory reaction in naïve MSCs through the FAK and MAPK signaling pathways, albeit negatively modulated by TGFβ signaling [126]. This evidence concerns the gene TGFB1 and neoplasm.